Let’s take a look at how Nxt-ID, Inc. (NXTD) surged in the after-hours session?
As of late afternoon trading, shares of Nxt-ID, Inc. (NASDAQ: NXTD) traded higher. The stock went to highs of over $1.06 at 14.72% in the late session, but the company has not announced any news since November 23, 2020. When the Company announced to hold the Annual Meeting of Stockholders at the company’s offices on […]
No matter why SCYNEXIS, Inc.(SCYX) shares dropped in the after-market hours
SCYNEXIS, Inc.(NASDAQ: SCYX) stock dropped -17.19% to $6.09 in the post-market session after the Nasdaq-listed company, confirmed that it has commenced a public offering of warrants to purchase a share of SCYNEXIS common stock, including pre-funded warrants to purchase common stock in lieu of shares for certain purchasers. Shares of common stock and warrants in the […]
This Farmmi (FAMI),update triggered its share price in the Post-market trading
Farmmi, Inc. (NASDAQ: FAMI), shares rose 16.41 to $1.49 in the AH session after a producer of agricultural goods in China, reported continuing success with its most recent revenue win. Zhejiang Forest Food Co., Ltd., a subsidiary of Farmmi, has obtained another multi-product order, this one from a Japanese client. Sliced black fungus and Tea […]
Pre-Market Top Losers Today
Pre-market data show Apartment Investment and Management Company (NYSE:AIV) is -6.55% lower at $4.71 after reporting that it has completed separation of Apartment Income REIT Corp. It recently closed at $5.04, fluctuating in a day’s range from $4.88 to $6.48. Scotiabank has a Sector perform rating on AIV’s shares and set a $41 price target. […]
Is that Why vTv Therapeutics (Nasdaq: VTVT) Inc shares drowned in the late hours last night?
vTv Therapeutics (Nasdaq: VTVT) shares thwarted in the after-market hours to -37.71% to $1.85 after the company revealed that it had signed a worldwide license agreement with Anteris Bio for the world’s first clinical-stage Nrf2 activator compound, HPP971. The biotech investment firm Aditum Bio, co-founded in 2019 by former Novartis executives Joe Jimenez and Dr. […]
Desktop Metal (DM) saw a big dip in the premarket despite last week’s IPO
Desktop Metal (DM) stock price dropped almost 30% to $17.35 during the premarket trading session. There doesn’t appear to be any company’s exclusive update that caused DM’sshare price to drop that much today, and investors may want to take notice of this development. Last week, Burlington-based Desktop Metal Inc. (NYSE: DM) gained public exposure on […]
So, that’s why Kezar Life Sciences, Inc. (KZR) stock peaked in the after-hours session
Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020. The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq […]
Top Four AI Stocks To Buy In Long Run
Slowly but surely, Artificial Intelligence (AI) is becoming a new area of contestation in the world market. AI provided services are growing in number with the passage of each day and global spending on AI is estimated to have increased by more than 12 per cent this year alone. This might have also been contributed […]
Why Socket Mobile, Inc. (NASDAQ: SCKT) jumped in the pre-market session?
In the pre-market session, the stock of Socket Mobile, Inc. (NASDAQ: SCKT) rose almost 52 percent to $4.06, amid no reports or press releases from the Computerhardware business. So, what is the question in your mind? And why is the stock breaking barriers today? Here is the last update for curious investors to learn about Socket Mobile, Inc. On November 18,2020, […]
Pfizer (PFE), BioNTech (BNTX) Rise On Vaccine Development, Tesla (TSLA), General Motors (GM) Surged For S&P 500 News
BioNTech SE (BNTX) was up 4 percent while Pfizer Inc (PFE) rose 0.78 percent on Wednesday. American Pfizer and its German partner BioNTech, recently outperformed by Moderna Inc (MRNA) (-4.5 percent), revealed on Wednesday that their Covid-19 vaccine candidate was actually 95 percent successful, according to the final review of phase 3 clinical trials. In […]
